The Financial Industry Regulatory Authority (FINRA) reports important information about securities broker Michael Pellegrino AKA Michael August Pellegrino [CRD#: 5900843, Oakbrook Terrace, IL]. However, Pellegrino denies the allegations. Read on to learn more about the allegations against Pellegrino. FINRA Sanctions Taylor Capital Management Inc. Securities Broker For Failure To Comply Evidently, on May 27, 2022, […]

The Financial Industry Regulatory Authority (FINRA) reports allegations of sales practice violations by securities broker Nikolay Zotenko [CRD #: 6334022, Beverly Hills, CA]. Zotenko worked for Morgan Stanley from 2015-2021. Notably, FINRA sanctioned the securities broker. However, Zotenko denies the allegations. Read the following summary of the FINRA enforcement action to learn more about the […]

Soreide Law Group is investigating possible investor claims against securities broker Michael Ovitt [CRD#: 1012040, Williamsville, New York]. Specifically, FINRA BrokerCheck discloses that investors disputed the sales practices of the securities broker, who worked for firms including Wells Fargo Advisors. Evidently, one or more clients allege sales practice violations in these disputes, including unauthorized transactions. […]

Soreide Law Group is examining potential investor disputes concerning securities broker Marlyn Leroy McClain, aka Marlyn McClain and Marylou McClain (CRD#: 325415, Elkhorn, Nebraska). Evidently, McClain joined NYLife Securities LLC as a securities broker in October 1982. Currently, BrokerCheck shows that four investors filed disputes concerning suitability and representations relating to insurance transactions. Here's a […]

Jeffrey Rachlin (CRD #823547, Registered Principal, Pleasantville, New York)   has submitted a Letter of Acceptance, Waiver and Consent in which he was fined $10,000, suspended from association with any FINRA member in any capacity for 30 business days, and suspended from association with any FINRA member in any principal capacity for 18 months. The […]

Securities attorney, Lars Soreide, of Soreide Law Group, PLLC, is currently investigating the Dendreon Corp. (NASDAQ: DNDN) for possible violations of federal securities laws after the company’s withdrawal of its sales forecasts for its prostate cancer therapy Provenge. Dendreon projected that it would earn between $350 - $400 million on sales of Provenge. The Dendreon Corporation is […]